社区获得性肺炎
肺炎
医学
计算机科学
重症监护医学
人工智能
内科学
作者
Catia Cillóniz,Logan Ward,Mads Lause Mogensen,Juan Manuel Pericàs,Raúl Méndez,Albert Gabarrús,Miquel Ferrer,Carolina García‐Vidal,Rosario Menéndez,Antoní Torres
出处
期刊:Chest
[Elsevier BV]
日期:2022-07-16
卷期号:163 (1): 77-88
被引量:60
标识
DOI:10.1016/j.chest.2022.07.005
摘要
Abstract
Background
Artificial intelligence tools and techniques such as machine learning (ML) are increasingly seen as a suitable manner to increase the prediction capacity of currently available clinical tools, including prognostic scores. However, studies evaluating the efficacy of ML methods in enhancing the predictive capacity of existing scores for community-acquired pneumonia (CAP) are limited. We aimed to apply and validate a causal probabilistic network (CPN) model to predict mortality in patients with CAP. Research question
Is a CPN model able to predict mortality in patients with CAP better than the commonly-used severity scores? Study design and methods
Derivation-validation retrospective study conducted in two Spanish University hospitals. The ability to predict 30-day mortality of a CPN designed to predict mortality in sepsis (SeF) and adapted for CAP (SeF-ML) was assessed and compared to other scoring systems (PSI, SOFA, qSOFA and CURB-65). The SeF models are proprietary software. Differences between ROC curves were assessed using De Long's method for correlated ROC curves. Results
The derivation cohort comprised 4,531 patients whilst the validation cohort had 1,034 patients. In the derivation cohort, the AUC of SeF-ML, CURB-65, SOFA, PSI and qSOFA were 0.801, 0.759, 0.671, 0.799 and 0.642, respectively, for 30-day mortality prediction. In the validation study, the AUC of SeF-ML was 0.826, concordantly with the AUC (0.801) in the derivation data (p=0.51). The AUC of SeF-ML was significantly higher than those of CURB-65 (0.764, p=0.03) and qSOFA (0.729, p=0.005). However, it did not differ significantly from PSI (0.830, p=0.92) and SOFA (0.771, p=0.14). Interpretation
SeF-ML shows potential for improving mortality prediction amongst patients with CAP using structured health data. Additional external validation studies should be conducted to support generalisability.
科研通智能强力驱动
Strongly Powered by AbleSci AI